Skip to content

APOTHEEK OPLINTER

Active
Private limited companyfounded 2011active for 14 yearsSint-Genovevaplein(OPL) 45, 3300 Tienen, BelgiumKBO/BCE: BE 0841.745.214
Summary

APOTHEEK OPLINTER has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €205,813 and a net result of €14,193. Equity has been growing by about 11% per year since 2019. Its solvency ranks better than 44% of 12,777 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Overview

Official details

Source: KBO
Status
Active since 28-11-2011 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 31-03-2025
Establishment unit
2.205.554.326 3300 Tienen, since 28-11-2011
Financial year end
31 March
Peppol
Reachable

Board and ownership

Board
  • PILOSTADirector · permanent representative Stefanie Tanghe

Financial position

70 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.6%
Annual accounts to 31-03-2025
Gross margin
€78,774
▼ 31.4%
Turnover
≈ €380,000
estimated
Profit
€14,193
▼ 74.8%
Equity
€205,813
▲ 7.4%
Total assets
€660,222
▲ 4.0%
Employees on 31-03-2025
1
=
  • 2026 accounts not filed, 3 days past the deadline
Score breakdownraises riskFigures for financial year 2025 (filed on 04-11-2025)Sector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.41, cash €157,720, halvedFounded in 2011Show the evidence

Checked score

Score 2025
70 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 47% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Average
Solvency 56+1
equity 31.2% of total assets
Liquidity 43-20
short-term debt 68.3% · cash 23.9%
Profitability 59-21
return on assets 2.1%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%

About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,281 companies, NACE 47, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025lowest value 05-2025: 0.1%● unchanged vs 04-2025lowest value 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.2%▲ +0.1 percentage points vs 09-2025 11-2025: 0.3%▲ +0.1 percentage points vs 10-2025 12-2025: 0.2%▼ -0.1 percentage points vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.5%▲ +0.3 percentage points vs 09-2026 11-2026: 0.6%▲ +0.1 percentage points vs 10-2026highest value
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.41 (1.4 in 2024), below the usual 1.5. Short-term debt is 68.3% and cash 23.9% of total assets. 68.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 47% of them on solvency, 42% on liquidity, 41% on profitability and 56% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Figures for financial year 2025 (filed on 04-11-2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.41, cash €157,720, halved
NBB · annual accounts
lowers risk · Founded in 2011
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · A punctual record breaks
This company filed 4 consecutive financial years on time. The year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 03-11-2025, 3 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filings
Deviation from the deadline
2026
not filed
2025
3 days late
2024
16 days early
2023
21 days early
2022
3 days early
2021
34 days early
2020
20 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 9 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

  1. · Gazette deed Company renamed from APOTHEEK STEFANIE TANGHE to APOTHEEK OPLINTERChange of role: PILOSTA, from manager to director · Permanent representative: Stefanie Tanghe
  2. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as APOTHEEK OPLINTER: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €533,000 and €871,000, founded between 2006 and 2016.

CompanyTotal assetsGross margin
APOTHEEK OPLINTER Tienen€660,222€78,774
APOTHEEK VISSENAKEN Tienen€563,660€89,546
Apotheek MOENS-MAMPAEY Niel€584,688€99,311
Bella Donna Pharma Scherpenheuvel-Zichem€655,308€103,339
PHARMACIE VANHOUTTE Mont-de-l'Enclus€532,913€82,543
Apotheek de Merode Mechelen€648,325€124,252
Apotheek Plaza Roeselare€871,423€108,672
Full comparison

Key facts about APOTHEEK OPLINTER

What is the company number of APOTHEEK OPLINTER?
The company number of APOTHEEK OPLINTER is 0841.745.214. The VAT number is the same number with BE in front: BE 0841.745.214.
Where is APOTHEEK OPLINTER based?
The registered office is at Sint-Genovevaplein(OPL) 45, 3300 Tienen.Company details
What does APOTHEEK OPLINTER do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK OPLINTER?
The legal form of APOTHEEK OPLINTER is Private limited company (BV).
When was APOTHEEK OPLINTER founded?
APOTHEEK OPLINTER was founded on 28-11-2011.
Is APOTHEEK OPLINTER still active?
Yes, APOTHEEK OPLINTER is an active enterprise in the KBO register.
How many employees does APOTHEEK OPLINTER have?
APOTHEEK OPLINTER had an average of 0.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK OPLINTER fall under?
In its 31-03-2025 annual accounts, APOTHEEK OPLINTER states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of APOTHEEK OPLINTER?
The turnover in financial year 2025 is ≈ €380,000. This figure is estimated from the gross margin of €78,774 and 73 comparable companies (NACE 477). It probably lies between €190,000 and €550,000.
Is APOTHEEK OPLINTER profitable?
In financial year 2025, APOTHEEK OPLINTER made a profit of €14,193.
Where can I find the annual accounts of APOTHEEK OPLINTER?
APOTHEEK OPLINTER filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.